for dulaglutide, within 3 days
Mitochondrion 54 , 17 (2020)
rskov, L
Long-Acting strategies for GLP-1 RAs, source: Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide: Comparing Residues Between Tirzepatide, GLP-1, and GIP, Drug Design, Development and Therapy, Oral Formulation The only available oral GLP-1RA is semaglutide (Rybelsus, Novo Nordisk)
Obtaining definitive proof of synapses would require systematic reconstruction using serial electron microscopy on a large population of enteroendocrine cells
According to Novo Nordisk and independent reporting, the approval was based on strong clinical trial results demonstrating meaningful weight loss outcomes